In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3-Amino-1-carboxymethyl-ß-lactams as Inhibitors of Penicillin-Binding Proteins of Resistant Bacteria.
Chemistry
; 24(57): 15254-15266, 2018 Oct 12.
Article
em En
| MEDLINE
| ID: mdl-29882610
ABSTRACT
As a complement to the renowned bicyclic ß-lactam antibiotics, monocyclic analogues provide a breath of fresh air in the battle against resistant bacteria. In that framework, the present study discloses the in silico design and unprecedented ten-step synthesis of eleven nocardicin-like enantiomerically pure 2-{3-[2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido]-2-oxoazetidin-1-yl}acetic acids starting from serine as a readily accessible precursor. The capability of this novel class of monocyclic 3-amino-ß-lactams to inhibit penicillin-binding proteins (PBPs) of various (resistant) bacteria was assessed, revealing the potential of α-benzylidenecarboxylates as interesting leads in the pursuit of novel PBP inhibitors. No deactivation by representative enzymes belonging to the four ß-lactamase classes was observed, while weak inhibition of class C ß-lactamase P99 was demonstrated.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Enterococcus faecium
/
Beta-Lactamas
/
Proteínas de Ligação às Penicilinas
/
Escherichia coli
/
Antibacterianos
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article